| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| REVENUES | $3.0M-23.9% | $4.0M+30.7% | $3.0M+356.1% | $665K |
| COST OF REVENUES | $2.1M-23.6% | $2.8M+11.2% | $2.5M+54.8% | $1.6M |
| GROSS PROFIT | $871K-24.7% | $1.2M+127.3% | $509K+152.7% | -$966K |
| RESEARCH AND DEVELOPMENT EXPENSES | $9.6M+40.0% | $6.9M+22.9% | $5.6M+33.5% | $4.2M |
| SALES AND MARKETING EXPENSES | $2.3M+91.1% | $1.2M+9.8% | $1.1M+58.7% | $699K |
| GENERAL AND ADMINISTRATIVE EXPENSES | $7.0M+26.6% | $5.6M+25.5% | $4.4M+23.9% | $3.6M |
| OPERATING LOSS | -$18.1M-45.0% | -$12.5M-17.6% | -$10.6M-12.6% | -$9.4M |
| FINANCING INCOME, NET | $1.1M+48.6% | $740K-25.1% | $988K | — |
| NET LOSS | -$17.0M-44.8% | -$11.8M-24.6% | -$9.4M+0.2% | -$9.5M |
| Net loss per share basic | -$1070.00-3.9% | -$1030.00-5.1% | -$980.00+26.3% | -$1330.00 |
| Net loss per share diluted | -$1070.00-3.9% | -$1030.00-5.1% | -$980.00+26.3% | -$1330.00 |
| Weighted average common shares basic | 15.9M+38.9% | 11.4M+18.4% | 9.7M+35.7% | 7.1M |
| Weighted average common shares diluted | 15.9M+38.9% | 11.4M+18.4% | 9.7M+35.7% | 7.1M |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.